Stroke and bleeding with NOAC and warfarin in patients with non-valvular atrial fibrillation in the Stockholm healthcare system

被引：0
|
作者：
Forslund, T. [1 ]
Wettermark, B. [1 ]
Hjemdahl, P. [1 ]
机构：
[1] Karolinska Inst, Dept Med Solna, Stockholm, Sweden
来源：
EUROPEAN HEART JOURNAL | 2016年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3987
引用
收藏
页码：792 / 792
页数：1
相关论文
共 50 条
  • [1] TRENDS AND PREDICTORS OF NOAC VERSUS WARFARIN USE FOR STROKE PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Brownell, Kenneth B.
    Sezer, Ahmet
    Jain, Sandeep
    Thoma, Floyd
    Kancharla, Krishna
    Bhonsale, Aditya
    Saba, Samir
    Mulukutla, Suresh
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 518 - 518
  • [2] Ischemic Stroke and Bleeding Risk in Patients with Non-valvular Atrial Fibrillation Treated with Warfarin
    He, S. B.
    Yu, S. H.
    Meng, R.
    Ru, S. W.
    Gong, Z. J.
    Liu, H. M.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 : S406 - S406
  • [3] Warfarin in non-valvular atrial fibrillation
    Dalby, A. J.
    Wessels, P.
    Opie, L. H.
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2013, 103 (12): : 901 - 904
  • [4] WARFARIN DISCONTINUATION AND STROKE RISK AMONG PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Wang, J.
    Qiao, Y.
    Spivey, C. A.
    Liu, X.
    Phatak, H.
    Mardekian, J.
    Claflin, A. B.
    Kachroo, S.
    Abdulsatter, Y.
    Parker, R. B.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A8 - A9
  • [5] Warfarin utilization and stroke risk in patients with chronic non-valvular atrial fibrillation
    Boccuzzi, SJ
    Stephenson, JJ
    Kreilick, CA
    Beaulieu, JF
    Hauch, O
    Kim, J
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 335A - 335A
  • [6] A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system
    Villines, Todd C.
    Schnee, Janet
    Fraeman, Kathy
    Siu, Kimberly
    Reynolds, Matthew W.
    Collins, Jenna
    Schwartzman, Eric
    [J]. THROMBOSIS AND HAEMOSTASIS, 2015, 114 (06) : 1290 - 1298
  • [7] STROKE PROPHYLAXIS WITH WARFARIN AND DABIGATRAN FOR PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION - A COST ANALYSIS
    Ali, A. N.
    Bailey, C.
    Abdulhafiz, A. H.
    [J]. AGE AND AGEING, 2013, 42 : 31 - 31
  • [8] Healthcare costs before and after stroke in patients with non-valvular atrial fibrillation who initiated treatment with rivaroxaban or warfarin
    Milentijevic, Dejan
    Lin, Jennifer H.
    Chen, Yen-Wen
    Kogan, Emily
    Shrivastava, Shubham
    Sjoeland, Erik
    Alberts, Mark
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 212 - 217
  • [9] Stroke prevention in non-valvular atrial fibrillation: Can warfarin do better?
    Apostolakis, Stavros
    Lip, Gregory Y. H.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2011, 106 (05) : 753 - 754
  • [10] Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC A cohort study
    Martinez, Carlos
    Katholing, Anja
    Wallenhorst, Christopher
    Freedman, Saul Benedict
    [J]. THROMBOSIS AND HAEMOSTASIS, 2016, 115 (01) : 31 - 39
12345